Jonathan Loree
@jonathanloree
GI Medical Oncologist at BC Cancer, Associate Professor at The University of British Columbia, Senior Investigator at the Canadian Cancer Trials Group (CCTG)
You might like
The "Big Bang" of cancer evolution: for colon cancer, evidence that immune evasion occurs very early nature.com/articles/s4158…
So Dill started this to help Canadian patients... and once he got the platform running for Canada... he made it global. In a weekend. Oh, Canada! @ccranorg @coloncanada @CAMO_ACOM @CDNCancerTrials @uoftmedicine @Sunnybrook @BCCancer @GillSharlene @jonathanloree @ocall0
Results from DYNAMIC-III RCT of ctDNA-guided adjuvant tx in stage III colon cancer in Nature Med. 🙏 to pts, providers & @JeanneTie 🇨🇦🇦🇺 @CDNCancerTrials & @GICancer Collab #ESMO2025 Presidential | Supported by @CIHR_IRSC & @cancersociety in 🇨🇦 🔗 rdcu.be/eLTj8
Excited to be at the #ESMO25 launch of the phase 3 @CDNCancerTrials 🇨🇦 #BATTMAN CO.33 BOT/BAL vs BSC in refractory MSS mCRC #unmetneed #trialsthatmatter Congrats to @jonathanloree 🙌 @ocall0 @Agenus_Bio @GICancer @JeanneTie Let’s get this done! 🇨🇦 🇦🇺 🇫🇷 @coloncanada…
Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM nejm.org/doi/10.1056/NE…
#ESMO25 @CDNCancerTrials GI disease site is in the house! 🙌 Looking forward to the 🌟 Presidential session later today for DYNAMIC III/CCTG CO.29 🎤 🇨🇦 🇦🇺 📌 ctDNA guided ACT de-escalation in stage3 CC @JeanneTie @jonathanloree @OncoAlert @GICancer #ESMOAmbassadors
Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC…
Exciting science and clinical efficacy in this @MDAndersonNews team science study led by @VanMorrisMD In Cancer Cell. Triple therapy with IO led to durable responses in BRAF V600E MSS colorectal cancer, showing promise. Randomized study ongoing. #crcsm cell.com/cancer-cell/fu…
Liquid biopsies in #CRC 🩸 Serial MRD monitoring: ✔️Detects recurrence 8–11 months earlier than imaging ✔️Improves sensitivity from 40–50% to 80–90% ✔️Helps monitor ACT response Liquid tumor-agnostic assays are evolving: now integrating ✅Methylation ✅Fragmentomics…
What if this was a drug ?🙂 🆕 NEJM | June 2025 🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer 📦 RCT | n=889 | Median FU: 7.9 yrs 🟠 3-yr structured aerobic program vs health ed alone 📈 Primary Endpoint: Disease-Free Survival (DFS) 🔹 HR 0.72…
Both hand cooling and compression were effective in preventing sensory chemotherapy-induced peripheral neuropathy during taxane-based chemotherapy. ja.ma/4ih0UDi @mbreckwoldt
Cell-free DNA (cfDNA) testing could improve colorectal cancer detection and reduce mortality in Canada, but it requires higher participation rates to be effective compared to current screening methods. ja.ma/4lUmTD1 @jonathanloree
12 lessons students learn in the Sinclair Lab: Lesson 1. Write the way you speak
New research: Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for #oesophagealcancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial thelancet.com/journals/lanon…
Just published in @JCO_ASCO the updated @ASCO guidelines on fertility preservation in people with #cancer: a must read for all colleagues involved in cancer care to increase awareness on #oncofertility issues @OncoAlert @AnnPartridgeMD @oncofertility Link: ascopubs.org/doi/10.1200/JC…
#GI25 ❤️ @ASCO So proud to see our past and present #oncology trainees thriving & making their mark! @jaypsv @jonathanloree @yeung_cynthia @howiel2013 🇨🇦 @BCCancer @UBCmedicine
@NCICTEP_ClinRes @SWOG @CDNCancerTrials #Coloncancer Task Force Chairs @smitha42 @jonathanloree hard at work at Oral Presentation session @ASCO #ASCOGI25 analyzing the LBA’s including BREAKWATER, CALGB80702, BESPOKE and CM 8HW. 👏 👏 💪💙
🔥off the press: The use of immunotherapy pre-liver transplant @JHepatology authors.elsevier.com/c/1kNgCcOnAUhMK 👉Hepatology Snapshot 👉Our thoughts on the use of ICI before liver transplant in HCC 👉Food for thoughts.. @myESMO @EASLedu @ILCAnews #livertwitter
Recently published: #ClonalHematopoiesis of Indeterminate Potential (CHIP) & Its Association with Treatment Outcomes & Adverse Events in Patients with Solid Tumours. doi.org/10.1158/2767-9… @jonathanloree @jaypsv @rob_vanner @PancreasBC @BCCancer #openaccess
United States Trends
- 1. Iowa 24.2K posts
- 2. Penn State 24.8K posts
- 3. Indiana 41.1K posts
- 4. Dante Moore 2,121 posts
- 5. Mendoza 22.1K posts
- 6. Gus Johnson 7,543 posts
- 7. Heisman 10.2K posts
- 8. #UFCVegas111 7,127 posts
- 9. Sayin 71.2K posts
- 10. Mizzou 4,636 posts
- 11. Cam Coleman N/A
- 12. #iufb 4,582 posts
- 13. Sounders N/A
- 14. Preston Howard N/A
- 15. Fran Brown N/A
- 16. Pringle 1,097 posts
- 17. Barcelos 1,060 posts
- 18. Stein 3,469 posts
- 19. Kirby Moore N/A
- 20. #LightningStrikes N/A
You might like
-
Dr. jordan berlin
@jordanberlin5 -
Sharlene Gill, MD, MPH, MBA, FASCO
@GillSharlene -
Scott Kopetz
@skopetz -
Mike Pishvaian
@MPishvaian -
Kohei shitara
@KoheiShitara -
Lizzy Smyth
@LizzySmyth1 -
Benjamin Weinberg, MD, FACP
@benweinbergmd -
Hagen Kennecke
@HKennecke -
Canadian Association of Medical Oncologists
@CAMO_ACOM -
Kristen Ciombor
@KristenCiombor -
Katrina Pedersen, MD, MS
@DrKatePedersen -
CCTG
@CDNCancerTrials -
#CRCTrialsChat
@CrcTrialsChat -
Anwaar Saeed
@AnwaarSaeed3 -
Van Morris, MD
@VanMorrisMD
Something went wrong.
Something went wrong.